Annual Report

Overview

The report presents 2021 as a transformational year for the company, marked by delivery of more than 2.6 billion COVID-19 vaccine doses to over 165 countries and regions. Consolidated total revenues reached €18,976.7 million, reflecting the rapid commercialization of its vaccine. The workforce grew to 3,138 employees at year-end, alongside continued global expansion. The report also sets a 42% absolute reduction target for Scope 1 and 2 emissions by 2030 against a 2021 base year.

Document

Report type: Annual Report
Class: Financial
Scope: Full report
Fiscal year: 2021
Period: 1 January 2021 – 31 December 2021
Publication date: 29 April 2022
Language: English
Pages
File size
Restatement: Disclosed

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services